INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ)

CUSIP: 45824V209

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM NEW
Total 13F shares
19,733,662
Share change
+296,314
Total reported value
$175,258,470
Put/Call ratio
201%
Price per share
$8.88
Number of holders
107
Value change
+$93,421
Number of buys
56
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 45824V209?
CUSIP 45824V209 identifies INSYQ - INSYS THERAPEUTICS INC NEW - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q3 2017

As of 30 Sep 2017, INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,733,662 shares. The largest 10 holders included ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Mirae Asset Global Investments Co., Ltd., NORGES BANK, Invesco Ltd., STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Folger Hill Asset Management LP, and NORTHERN TRUST CORP. This page lists 107 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.